openPR Logo
Press release

Cancer Immunotherapy Market Size Worth USD 153.03 Billion by 2027

09-07-2022 07:39 PM CET | Health & Medicine

Press release from: Emergen Research

Cancer Immunotherapy Market Size Worth USD 153.03 Billion

The global Cancer Immunotherapy Market is expected to reach USD 153.03 Billion by 2027, according to a new report by Emergen Research. The cancer immunotherapy market is growing at a substantial pace owing to the growing acceptance and inclination of the patients towards the newly invented advanced treatments over the conventional ones. In order to substantialize the severe and chronic diseases like cancer, every year, the cancer research centers invest a handful of the amount in their R&D, which fuels up the market growth by a large margin.

The key factors responsible for driving the growth of the cancer immunotherapy market include the technological advancements in treatment therapies, rise in the incidence of cancer, increasing number of R&D for the treatment of cancer, and improving the effectiveness of cancer immunotherapy for the treatment of a wide range of diseases such as lung cancer, breast cancer, skin cancer, and others. A big market limiting factor is the high price of the slow and long-term procedure, expensive treatment and R&D, and rigorous regulations by the government. Also, product approvals and high cost of treatment are expected to act as a restraining factor on the global market in the near future.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/63

Top Companies Operating in the Cancer Immunotherapy Market and Profiled in the Report are:

Bristol-Myers Squibb

Novartis International Ag

Celgene Corporation

Amgen Inc.

Amgen Inc.

Merck & Co. Inc.

Janssen Global Services

LLC

Seattle Genetics Inc

Printegra

Gristone Oncology

Inc

Pfizer Inc

The report further provides a comprehensive analysis of the competitive landscape and provides complete coverage with regard to company profiles, product portfolio, revenue generation, financial standing, and market position. It also covers mergers and acquisitions, joint ventures, product launches, brand promotions, collaborations, agreements, and partnerships, among others. It also offers insights into the manufacturing processes, revenue estimations, R&D advancements, and industrial penetration.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/63

For the purpose of this report, Emergen Research has segmented into the global Cancer Immunotherapy Market on the basis of technology, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2017-2027)

Monoclonal Antibodies

Vaccines

Checkpoint Inhibitors

Cell Therapies

Immune System Modulators

Adoptive Cell Transfer

Cytokines

Others

Application Outlook (Revenue, USD Billion; 2017-2027)

Head & Neck Cancer

Blood Cancers

Liver Cancer

Lung Cancer

Breast Cancer

Prostate Cancer

Melanoma

Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Cancer Specialty Centers

Hospitals and Clinics

The report aims to offers a thorough outlook of the Cancer Immunotherapy market based on various key elements, such as market drivers, limitations, threats, restraining factors, and growth prospects. The report aims to deliver a comprehensive understanding of the Cancer Immunotherapy market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/cancer-immunotherapy-market

Cancer Immunotherapy Market Segmentation by Regions:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Objectives of the Report:

The monoclonal antibodies are expected to have the largest market share in 2019. This is attributed to the fact that monoclonal antibodies have the largest class of drugs than other sectors of the cancer immunotherapy.

The cancer immunotherapy by application includes head and neck cancer as one of the prospects which are expected to fuel the market growth. The major drivers in the market are the increase in the diminishing lifestyle, which includes the use of tobacco, hike in smoking habit, and the upsurge in the incidences of infection caused by human papillomavirus (HPV), especially HPV type 16.

Hospitals and clinics dominated the cancer immunotherapy market during the forecast period. The majority of hospitals, particularly in the case of cancer immunotherapy, focuses on the treatment of symptomatic conditions. The hospitals and clinics provide cutting-edge treatments that harness a patient's own immune system to fight cancer. These include cancer vaccines, cellular therapies, and other experimental drugs.

The North America cancer immunotherapy market is anticipated to dominate the global market. The major driving factors for the growth of this market are the rise in the adoption rate of immunotherapy over the conventional treatments due to lesser side effects and more survival efficiency and an increase in the rate of cancer affected patients.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/63

Thank you for reading our report. For further queries regarding the report or customization options, please connect with us. Our team will ensure you get a report well-suited to your needs

Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Custom Intelligence services https://www.emergenresearch.com/custom-intelligence
Growth Consulting Services https://www.emergenresearch.com/growth-consultant
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/industry-report/cancer-immunotherapy-market

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Immunotherapy Market Size Worth USD 153.03 Billion by 2027 here

News-ID: 2727546 • Views:

More Releases from Emergen Research

Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Publi …
The global Bacteriophage Market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth. Bacteriophages have been shown to be
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | CAGR 23.6% - Published by Emergen Research
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | …
The global Internet of Behaviors (IoB) market size is expected to reach USD 3.087.86 Billion in 2032 and register a steady revenue CAGR of 23.6% over the forecast period, according to the latest analysis by Emergen Research. Stringent regulations on the use of Internet of Behaviors (IoB) in various industries and technological advancements of big data analytics and IoB technology are key factors driving market revenue growth. The use and
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 2032 | CAGR 13.9% - Published by Emergen Research
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 203 …
The global Consumer Internet of Things (IoT) Market size is expected to reach USD 334.78 Billion in 2032 and register a revenue CAGR of 13.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of smart devices and growing number of internet users is a major factor driving the market revenue growth. When using the Internet of Things for customer care, organizations can use the
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - Published by Emergen Research
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - P …
The Industrial Safety Market is experiencing robust growth, driven by the imperative need for workplace safety across various industries worldwide. Industrial safety encompasses a range of products, solutions, and services designed to protect workers, assets, and the environment from occupational hazards and accidents. With an increasing focus on compliance with stringent safety regulations, risk mitigation, and employee well-being, industries are investing in advanced safety technologies and practices. The market's expansion

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top